IRVING, Texas, May 8, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine pioneer, today announced that it has submitted an application to the New York State Department of Health (NYSDOH) Clinical...
Hence then, the article about caris life sciences submits application to new york state department of health for caris assure blood based testing authorization was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure Blood‑Based Testing Authorization )
Also on site :
- Aura Reports Second Quarter 2026 Financial Results, Highlights Strong Momentum Following Qoria Acquisition
- Infor Appoints Yuka Kanemitsu as President and Representative Director of Infor Japan to Accelerate Industry Cloud Growth and AI-Driven Business Transformation
- 360training Acquires Multiple Brands, Expanding Its Compliance Training Portfolio Across Healthcare, EHS, Food Safety, and Transportation
